Purchases and Sales Made in Q2 2024 in Evoke Pharma Inc (EVOK)
This table provides information about the institutional ownership of Evoke Pharma Inc (EVOK) during Q2 2024. The information is specifically focused on institutions that hold shares of Evoke Pharma Inc.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Aug 09, 2024
Q2 2024
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
22.6K+ 83.6% |
$9.73K - $14K
|
49.7K
$23.4K
|
|
|
Aug 14, 2024
Q2 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
11.9KNew |
$5.12K - $7.38K
|
11.9K
$5.6K
|
|
|
Aug 14, 2024
Q2 2024
|
State Street Corp
Boston, MA |
BUY
|
- |
10.7KNew |
$4.58K - $6.61K
|
10.7K
$5.01K
|
|
|
Aug 13, 2024
Q2 2024
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
74+ 1.0% |
$31.8 - $45.9
|
7.48K
$3.52K
|
|
|
Aug 14, 2024
Q2 2024
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
69New |
$29.7 - $42.8
|
69
$32.4
|
|
|
Jul 23, 2024
Q2 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Aug 14, 2024
Q2 2024
|
Altium Capital Management LP
New York, NY |
SELL
|
- |
-32.5K- 4.48% |
$14K - $20.2K
|
692K
$325K
|